Form 4 for HALO HALOZYME THERAPEUTICS, INC.

Accepted 2022-12-06 00:00:00 ET · period of report 2022-12-02 · accession 0001415889-22-012142 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2022-12-06	2022-12-02+	HALO	Posard Matthew L.	Dir	S - Sale	$56.89	-30.0K	115.2K	-21%	-$1.71M

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-12-06	S	D	10,000	$56.12	105,189	D	—	—	(F3) Represents a weighted average sales price per share. The shares were sold at prices ranging from $56.10 to $56.19. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
2	Common	Common Stock	2022-12-02	S	D	10,000	$58.80	125,189	D	—	—	(F1) Represents a weighted average sales price per share. The shares were sold at prices ranging from $58.80 to $58.83. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
3	Common	Common Stock	2022-12-05	S	D	10,000	$55.74	115,189	D	—	—	(F2) Represents a weighted average sales price per share. The shares were sold at prices ranging from $55.70 to $55.83. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.